Cargando…

High prevalence of hyperuricaemia and its impact on non-valvular atrial fibrillation: the cross-sectional Guangzhou (China) Heart Study

OBJECTIVES: There are country and regional variations in the prevalence of hyperuricaemia (HUA). The prevalence of HUA and non-valvular atrial fibrillation (NVAF) in southern China is unknown. DESIGN: A cross-sectional study. SETTING AND PARTICIPANTS: A total of 11 488 permanent residents aged 35 or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Wei-dong, Deng, Hai, Guo, Pi, Liu, Fang-zhou, Chen, Ru-yin, Fang, Xian-hong, Zhan, Xian-zhang, Liao, Hong-tao, Huang, Wen-xiang, Liu, Yang, Wang, Feng, Zheng, Mu-rui, Liu, Hua-zhang, Huang, Jun, Wei, Wei, Xue, Yu-mei, Wu, Shu-lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549638/ https://www.ncbi.nlm.nih.gov/pubmed/31147367 http://dx.doi.org/10.1136/bmjopen-2018-028007

Ejemplares similares

Association between elevated blood glucose level and non-valvular atrial fibrillation: a report from the Guangzhou heart study
por: Fu, Lu, et al.
Publicado: (2019)

Predictive value of serum uric acid on left atrial spontaneous echo contrast in non-valvular atrial fibrillation patients
por: Liao, Hong-Tao, et al.
Publicado: (2015)

Predictive value of red cell distribution width on left atrial thrombus or left atrial spontaneous echo contrast in patients with non-valvular atrial fibrillation
por: Zhan, Xian-Zhang, et al.
Publicado: (2018)

Multiple biomarkers and arrhythmia outcome following catheter ablation of atrial fibrillation: The Guangzhou Atrial Fibrillation Project
por: Deng, Hai, et al.
Publicado: (2018)

Epidemiological Characteristics of Atrial Fibrillation in Southern China: Results from the Guangzhou Heart Study
por: Deng, Hai, et al.
Publicado: (2018)

Cross-sectional association between gamma-glutamyl transferase and hyperuricaemia: the China Multi-Ethinic Cohort (CMEC) study
por: Wang, Yanjiao, et al.
Publicado: (2022)

Left atrial enlargement and non-paroxysmal atrial fibrillation as risk factors for left atrial thrombus/spontaneous Echo contrast in patients with atrial fibrillation and low CHA(2)DS(2)-VASc score
por: Lin, Wei-Dong, et al.
Publicado: (2020)

A U-shaped relationship of body mass index on atrial fibrillation recurrence post ablation: A report from the Guangzhou atrial fibrillation ablation registry
por: Deng, Hai, et al.
Publicado: (2018)

Hyperuricaemia and associated factors among the oldest-old population in the urban areas of Chengdu, China: a community-based cross-sectional study
por: Chen, Xiang-Ji, et al.
Publicado: (2021)

Prevalence and related factors of hyperuricaemia in Shanghai adult women of different ages: a multicentre and cross-sectional study
por: Tao, Min, et al.
Publicado: (2021)

Hyperuricaemia: prevalence and association with mortality in an elderly Finnish population
por: Timsans, Janis, et al.
Publicado: (2023)

Temporal trends in hyperuricaemia among adults in Wuhan city, China, from 2010 to 2019: a cross-sectional study
por: Wan, Zhengce, et al.
Publicado: (2021)

Automated Ultra–High Density Mapping in atrial fibrillation hybrid procedure
por: Liu, Fang–Zhou, et al.
Publicado: (2018)

Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK
por: García Rodríguez, Luis Alberto, et al.
Publicado: (2019)

Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study
por: Xiang, Wei, et al.
Publicado: (2015)

Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
por: Hu, Bo, et al.
Publicado: (2021)

Cohort protocol: Guangzhou High-Risk Infant Cohort study
por: Hu, Pian, et al.
Publicado: (2020)

Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study
por: Loo, Simone Y, et al.
Publicado: (2018)

Adiposity change and mortality in middle-aged to older Chinese: an 8-year follow-up of the Guangzhou Biobank Cohort Study
por: Huang, Ying Yue, et al.
Publicado: (2020)

Hemoglobin A1c and risk of left atrial thrombus and spontaneous echo contrast in non-valvular atrial fibrillation patients
por: Kuang, Rong-Ren, et al.
Publicado: (2017)

Management and Anticoagulation Treatment of Non-Valvular Atrial Fibrillation in Elderly Patients: The Dali Study
por: Huang, Hong, et al.
Publicado: (2023)

The Evolving Epidemiology of Elderly with Degenerative Valvular Heart Disease: The Guangzhou (China) Heart Study
por: He, Shangfei, et al.
Publicado: (2021)

Left Atrial Thrombus in Patients With Non-valvular Atrial Fibrillation: A Cross-Sectional Study in China
por: Shi, Shaobo, et al.
Publicado: (2022)

Anticoagulant Prescribing for Non‐Valvular Atrial Fibrillation in the Veterans Health Administration
por: Rose, Adam J., et al.
Publicado: (2019)

Population pharmacokinetic analysis for dabigatran etexilate in Chinese patients with non-valvular atrial fibrillation
por: Liu, Ya-ou, et al.
Publicado: (2022)

The association of trastuzumab with atrial fibrillation and heart failure in breast cancer patients in routine clinical practice: a population-based propensity score matching and competing risk model analysis
por: Wu, Wen-Chi, et al.
Publicado: (2022)

Platelet CD36 links overweight and a prothrombotic phenotype in patients with non-valvular atrial fibrillation
por: Wang, Hua, et al.
Publicado: (2022)

The predictive value of a concise classification of left atrial appendage morphology to thrombosis in non‐valvular atrial fibrillation patients
por: He, Jionghong, et al.
Publicado: (2020)

Anticoagulation Therapy for Non-valvular Atrial Fibrillation: A Mini-Review
por: Wu, Jia, et al.
Publicado: (2020)

A Study of Cardiogenic Stroke Risk in Non-valvular Atrial Fibrillation Patients
por: Song, Ziliang, et al.
Publicado: (2020)

Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease
por: Chen, Jian-Qin, et al.
Publicado: (2023)

Discontinuation of non-Vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: a population-based cohort study using primary care data from The Health Improvement Network in the UK
por: Ruigómez, Ana, et al.
Publicado: (2019)

Associations of meat, fish and seafood consumption with kidney function in middle-aged to older Chinese: a cross-sectional study based on the Guangzhou Biobank Cohort Study
por: Lu, Ting Yu, et al.
Publicado: (2023)

Association between use of amiodarone for non-valvular atrial fibrillation and patient survival: from the prospective China Atrial Fibrillation Registry
por: Hou, Xiao-Xia, et al.
Publicado: (2021)

Newer Anticoagulants for Non-Valvular Atrial Fibrillation
por: Harburger, Joseph M., et al.
Publicado: (2012)

Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation
por: Samaras, Athanasios, et al.
Publicado: (2021)

The Management of Hyperuricaemia
por: Bayliss, Richard, et al.
Publicado: (1984)

Risk factors associated with left atrial appendage thrombosis in patients with non-valvular atrial fibrillation by transesophageal echocardiography
por: Wang, Xingpeng, et al.
Publicado: (2023)

Safety and efficacy of direct oral anticoagulation in patients with and without radiofrequency ablation of non-valvular atrial fibrillation: a multicenter retrospective cohort study
por: Wu, Shuyi, et al.
Publicado: (2023)

Risk of Incident Non-Valvular Atrial Fibrillation after Dialysis-Requiring Acute Kidney Injury
por: Shiao, Chih-Chung, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sc6jbb3p3guf1eqr95mg8u2m8c